Top 17 Dermatology Investors in Europe
Top 17 Dermatology Investors in Europe
The dermatology practice industry in Europe focuses on diagnosing and treating skin conditions, ranging from acne to chronic diseases like psoriasis. This sector includes specialists, clinics, and companies developing innovative medical devices and skincare products. A rising trend is the integration of technology, with telemedicine and app-based solutions becoming popular for remote consultations. Consumers are increasingly looking for personalized skincare, prompting investment in research and development. The industry is set for growth as awareness about skin health expands, alongside advancements in dermatological science and technology, leading to improved treatments and consumer products.
The investors in our list display a mix of corporate, venture capital, and private equity firms, predominantly based in major cities like London, Paris, and Brussels. With either small or large team sizes, these firms span a range of ages, from established names founded in the early 20th century to newer entrants from the early 2000s. Some investors, like the European Innovation Council, made over 50 deals in 2024, demonstrating their active role in shaping the dermatology landscape.
Top 17 Dermatology Practice Investors in Europe
1. DigitalHealth.London
- Website: digitalhealth.london
- Type: Corporate
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 2016
- Headcount: 11-50
- Number of deals in 2024: 1
- LinkedIn: digitalhealth.london
DigitalHealth.London is a not-for-profit organization based in London, England, founded in 2016. It connects NHS staff, digital health companies, and academics to enhance health and care through digital innovation. The organization offers various programs, including the Accelerator and Digital Pioneer Fellowship, to support the adoption of digital solutions in the NHS. Notably, DigitalHealth.London has been involved in several transactions relevant to dermatology, such as Skin Analytics, which raised funds in a Seed Round in 2017, and SkinVision, which received Non Equity Assistance in 2019. Additionally, they supported Ampersand Health and MedicSpot, both of which also received Non Equity Assistance in 2019. These transactions highlight their active role in fostering digital health solutions that can impact dermatology practices.
2. SBRI Healthcare
- Website: sbrihealthcare.co.uk
- Type: Corporate
- Headquarters: Twickenham, England, United Kingdom (UK)
- Founded year: 2009
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn: sbri-healthcare
SBRI Healthcare is a not-for-profit healthcare innovation program based in Twickenham, England, founded in 2009. The organization provides funding and support to innovators and entrepreneurs who are addressing unmet health and care needs within the NHS and social care system. Their mission is to accelerate the development of innovative technologies and solutions that improve patient care and increase efficiencies in healthcare delivery. Notably, SBRI Healthcare has been involved in several relevant transactions in the dermatology space, including grants to Skin Analytics, which raised over $2 million in 2022 and over $100,000 in 2017, both aimed at enhancing skin health analytics. Additionally, they have supported Blueberry Therapeutics, which raised funds for dermatological applications, and other healthcare initiatives that may intersect with dermatology. This track record demonstrates their active role in funding innovations that can benefit dermatology practices.
3. Unilever Ventures
- Website: unileverventures.com
- Type: Corporate
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 2002
- Headcount: 11-50
- Number of deals in 2024: 9
- LinkedIn: unileverventures
Unilever Ventures is a corporate venture capital firm based in London, England, founded in 2002. The firm specializes in investing in emerging brands and technologies, particularly within the beauty and wellness sectors. They provide capital and leverage Unilever's extensive network to help startups grow. Notably, Unilever Ventures has invested in several skincare brands that are relevant to dermatology, such as Minimalist, an Indian skincare brand that raised $15 million in Series A funding to enhance its infrastructure and R&D capabilities. They also invested in Gallinée, a skincare brand focused on developing its product range and expanding into new markets. Additionally, they participated in funding for ZitSticka, a tech skincare brand, which indicates their interest in innovative skincare solutions. These transactions highlight Unilever Ventures' commitment to empowering entrepreneurs in the skincare industry, making them a significant player in the dermatology practice context.
4. European Innovation Council (EIC)
- Website: eic.ec.europa.eu
- Type: Corporate
- Headquarters: Brussels, Brussels, Belgium
- Founded year: 1958
- Headcount: 201-500
- Number of deals in 2024: 57
- LinkedIn: european-innovation-council-eic
The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, the EIC offers various funding programs, including the EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale their technologies. The EIC also provides business acceleration services, networking opportunities, and prizes to foster innovation in diverse sectors. Notably, the EIC has been involved in funding dermatology-related companies, such as Dermagnostix, which raised $2,750,488 through a grant in March 2022, and S-Biomedic, which received both venture funding and grants totaling $1,427,135 in October 2019. Additionally, Legacy Healthcare and Plasmacure are other companies that have benefited from EIC funding, further demonstrating the EIC's engagement in the dermatology practice context.
5. L'Oréal
- Website: loreal.com
- Type: Corporate
- Headquarters: Paris, Île-De-France, France
- Founded year: 1909
- Headcount: 10001+
- Number of deals in 2024: 4
- LinkedIn: lor%c3%a9al
L'Oréal S.A. is a leading cosmetics manufacturer based in Paris, specializing in a wide range of personal care products, including skin care, make-up, hair care, and perfumes. Founded in 1909, the company has a strong commitment to innovation and sustainability. L'Oréal has made several strategic acquisitions and investments in the dermatology space, including the acquisition of CeraVe in 2017, a brand known for its dermatologist-recommended skincare products. Additionally, L'Oréal's involvement with Galderma, which focuses on dermatological solutions, further emphasizes their commitment to this sector. Other notable transactions include the acquisition of Skinceuticals, a skincare brand, and Decléor S.A. and Carita International, which also align with their dermatological interests. These activities highlight L'Oréal's active role in the dermatology practice industry, beyond their core cosmetics business.
6. EQT Group
- Website: eqtgroup.com
- Type: Private Equity
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1994
- Headcount: 1001-5000
- Number of deals in 2024: 30
- LinkedIn: eqt-partners
EQT Group is a private equity investment firm based in Stockholm, Sweden, founded in 1994. The firm specializes in various investment strategies, including private equity, infrastructure, real estate, growth equity, and venture capital. EQT serves institutional investors by providing expertise in managing diverse investment portfolios across multiple sectors and geographies. Notably, EQT led a consortium to acquire Galderma, the largest independent global dermatology company, from Nestlé for CHF 10.2 billion ($10.1 billion) in October 2019. This acquisition highlights EQT's strategic focus on the dermatology sector. Additionally, EQT has made significant investments in healthcare, including the acquisition of Terveystalo Healthcare and Icon Group, further demonstrating their commitment to expanding their footprint in the healthcare industry.
7. Crowdcube
- Website: crowdcube.com
- Type: Corporate
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 2010
- Headcount: 51-200
- Number of deals in 2024: 3
- LinkedIn: crowdcube-limited
Crowdcube is a London-based crowdfunding platform founded in 2010 that enables businesses to raise capital through equity investments. It connects startups and SMEs with potential investors, facilitating the funding process. The platform promotes diversity and inclusion within its workforce while providing investment management services to its clients. Crowdcube has been involved in several relevant transactions in the healthcare sector, including London Doctors Clinic, which raised $36,380 in March 2022, and Nursem, which raised $801,151 in October 2023. These transactions highlight Crowdcube's engagement with businesses that operate within the dermatology practice context, making it a significant player in this investment space.
8. Agoranov
- Website: agoranov.com
- Type: Corporate
- Headquarters: Paris, Île-De-France, France
- Founded year: 2000
- Headcount: 11-50
- Number of deals in 2024: 42
- LinkedIn: agoranov
Agoranov is a startup incubator based in Paris, Île-De-France, founded in 2000. The firm specializes in supporting technology and science startups through personalized assistance, fully equipped facilities, and acceleration programs. They primarily focus on early-stage startups across various innovative sectors. Notably, Agoranov has been involved in several transactions relevant to the dermatology practice context, including investments in Pictaderm, DAMAE Medical, and Skintifique, all of which are companies that develop solutions in the dermatology field. These investments highlight Agoranov's commitment to fostering growth in the dermatology sector, alongside their broader focus on technology and science startups.
9. AstraZeneca
- Website: astrazeneca.com
- Type: Venture Capital
- Headquarters: Cambridge, England, United Kingdom (UK)
- Founded year: 1999
- Headcount: 10001+
- Number of deals in 2024: 9
- LinkedIn: astrazeneca
AstraZeneca is a pharmaceutical and biotechnology company founded in 1999, headquartered in Cambridge, England. It develops and manufactures a wide range of medications and vaccines targeting major diseases, with a strong emphasis on research and development to address pressing healthcare challenges. Notably, AstraZeneca acquired Almirall in July 2014, a company known for its focus on dermatology, which highlights AstraZeneca's commitment to expanding its portfolio in this area. Additionally, AstraZeneca has been involved in various grant transactions aimed at supporting healthcare initiatives, although these are less directly related to dermatology. Overall, AstraZeneca's strategic acquisition of Almirall positions it as a relevant player in the dermatology practice industry.
10. Bgf
- Website: bgf.co.uk
- Type: Venture Capital
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 2011
- Headcount: 51-200
- Number of deals in 2024: 53
- LinkedIn: bgfinvestments
BGF Investment Management Limited is a venture capital firm based in London, UK, founded in 2011. The firm specializes in providing growth funding and value creation support to small and mid-sized businesses across the UK and Ireland. BGF addresses the funding gap in the market by making minority investments and offering extensive support services to help businesses scale. Notably, BGF has invested €7 million in The Avoca Clinic, a cosmetic surgery outfit with three locations in Ireland, indicating their interest in the healthcare sector, particularly in areas related to dermatology and cosmetic treatments. Other transactions include investments in Abbey Pharma, OCL Vision, Bayfields Opticians & Audiologists, and Scottish Dental Care Group, showcasing their diverse portfolio in the healthcare and wellness industries, which may align with dermatology practices seeking growth and expansion.
11. Octopus Ventures
- Website: octopusventures.com
- Type: Venture Capital
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 2008
- Headcount: 51-200
- Number of deals in 2024: 37
- LinkedIn: octopus-ventures
Octopus Ventures is a venture capital firm based in London, England, founded in 2008. They specialize in backing founders and startups across various sectors, including B2B Software, Bio, Climate, Consumer, Deep Tech, Fintech, and Health. Notably, they have invested in Skin + Me, which secured £10m in a Series B funding round to enhance its personalized skincare strategy and online prescription service. This investment highlights Octopus Ventures' commitment to supporting innovative health solutions. Additionally, they have participated in other health-related ventures, such as TympaHealth, which focuses on digitized assessments of ear and hearing health, further demonstrating their engagement in the health sector.
12. Cvc
- Website: cvc.com
- Type: Private Equity
- Headquarters: Luxembourg
- Founded year: 2005
- Headcount: 1001-5000
- Number of deals in 2024: 16
- LinkedIn: cvc-capital-partners
CVC Capital Partners is a prominent investment firm specializing in private equity, credit, secondaries, and infrastructure, managing approximately €193 billion in assets for over 1000 clients, including pension funds and institutional investors. Founded in 2005 and based in Luxembourg, CVC has made significant strides in the healthcare sector through various strategic acquisitions. Notable transactions include the acquisition of Mehilainen, a healthcare provider, and stakes in hospital chains such as PT Siloam International Hospitals and Hellenic Healthcare Group. These investments reflect CVC's commitment to delivering sustainable value and growth in the healthcare industry, which may include dermatology practices as part of their broader investment strategy.
13. Unilever
- Website: unilever.com
- Type: Corporate
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 1872
- Headcount: 10001+
- LinkedIn: unilever
Unilever PLC is a multinational consumer goods company based in London, England, founded in 1872. It offers a diverse range of products, including food, beauty, personal care, and cleaning agents, with a strong emphasis on sustainability. Unilever aims to make sustainable living commonplace through its extensive product offerings. In recent years, Unilever has made significant strides in the skincare sector, acquiring several prominent brands that are relevant to dermatology practices. Notable transactions include the acquisition of Kate Somerville Skincare in May 2015, Dermalogica in August 2023, Murad in July 2015, and Paula's Choice in June 2021 for approximately $2 billion. These acquisitions enhance Unilever's portfolio in the premium skincare segment and demonstrate its commitment to the dermatology and skincare market.
14. Apax
- Website: apax.com
- Type: Private Equity
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 1981
- Headcount: 201-500
- Number of deals in 2024: 8
- LinkedIn: apax-partners
Apax Partners LLP is a private equity firm based in London, England, founded in 1981. The firm specializes in managing investments across various sectors, including technology, internet/consumer, healthcare, and services. Apax collaborates with management teams of high-potential companies to drive growth and innovation, serving institutional investors seeking to enhance their capital through strategic investments in private equity funds. Notably, Apax has made significant investments in the dermatology sector, including the acquisition of Syneron Candela for approximately $397 million, which focuses on aesthetic medical devices. Additionally, Apax has participated in funding rounds for SkinMedica, a skincare company, showcasing their commitment to the dermatology practice industry. These transactions highlight Apax's strategic interest in companies that operate within the dermatology and aesthetic medicine space.
15. Index Ventures
- Website: indexventures.com
- Type: Venture Capital
- Headquarters: London, England, United Kingdom (UK)
- Founded year: 1996
- Headcount: 51-200
- Number of deals in 2024: 67
- LinkedIn: index-ventures
Index Ventures is a venture capital firm founded in 1996, based in London, England. The firm invests in innovative startups across various sectors, including technology and healthcare. They provide capital and strategic support to entrepreneurs, helping them navigate the challenges of growing their businesses. Notably, Index Ventures has invested in GetHarley, a global online consultation gateway that connects clinicians with consumers, raising £40.6 million in a Series B funding round in June 2023, and previously $12 million in a Series A round in April 2021. This investment highlights their commitment to enhancing healthcare access, particularly in dermatology. Additionally, they have invested in Allara, which raised $26 million in a Series B round in January 2025, further indicating their focus on healthcare solutions. Index Ventures aims to build long-term partnerships with founders to drive success, making them a significant player in the healthcare investment landscape.
16. Eurazeo
- Website: eurazeo.com
- Type: Private Equity
- Headquarters: Paris, Île-De-France, France
- Founded year: 1969
- Headcount: 201-500
- Number of deals in 2024: 40
- LinkedIn: eurazeo
Eurazeo is a prominent investment management firm based in Paris, specializing in private equity, private debt, and real assets. Founded in 1969, the firm has established a significant presence in the investment management landscape, particularly in Europe. Eurazeo focuses on tailored investment strategies aimed at fostering growth and expansion across various sectors, including technology and healthcare. Notably, Eurazeo has made strategic investments in the dermatology and skincare space, such as acquiring a majority stake in Beekman 1802, a clean skin care company, for a total investment of US$62 million. This acquisition aims to support Beekman 1802's expansion across various channels and geographies, highlighting Eurazeo's commitment to the skincare market. Additionally, their involvement with Horus Pharma, which raised over $25 million in a venture round, further emphasizes their interest in dermatological products. Their investment in Avi Medical, a healthcare platform planning to launch physical clinics, also indicates a broader commitment to healthcare services, which may encompass dermatology practices.
17. Partech
- Website: partechpartners.com
- Type: Venture Capital
- Headquarters: Paris, Île-De-France, France
- Founded year: 1982
- Headcount: 51-200
- Number of deals in 2024: 24
- LinkedIn: partech
Partech Partners is a venture capital firm founded in 1982, based in Paris, Île-De-France, France. The firm specializes in providing funding and support to startups across various sectors, particularly in technology. Partech operates globally and has a diverse portfolio of companies. Notably, they have invested in DAMAE Medical, a medtech company that raised €2M for the development of a technology relevant to dermatology, indicating their interest in healthcare innovations. Additionally, they participated in funding rounds for other healthcare-related startups, such as Happytal, which focuses on healthcare facilities, further showcasing their engagement in the healthcare sector. Partech's strategic advisory services and investment capabilities position them as a supportive partner for startups in the dermatology practice industry.
Dermatology Practice Insights: Key Investors in Europe
Investor | Headquarter | Size | Founded | Deals 2024 |
---|---|---|---|---|
DigitalHealth.London | London, England, United Kingdom (UK) | 11-50 | 2016 | 1 |
SBRI Healthcare | Twickenham, England, United Kingdom (UK) | 11-50 | 2009 | 3 |
Unilever Ventures | London, England, United Kingdom (UK) | 11-50 | 2002 | 9 |
European Innovation Council (EIC) | Brussels, Brussels, Belgium | 201-500 | 1958 | 57 |
L'Oréal | Paris, Île-De-France, France | 10001+ | 1909 | 4 |
EQT Group | Stockholm, Stockholm, Sweden | 1001-5000 | 1994 | 30 |
Crowdcube | London, England, United Kingdom (UK) | 51-200 | 2010 | 3 |
Agoranov | Paris, Île-De-France, France | 11-50 | 2000 | 42 |
AstraZeneca | Cambridge, England, United Kingdom (UK) | 10001+ | 1999 | 9 |
Bgf | London, England, United Kingdom (UK) | 51-200 | 2011 | 53 |
Octopus Ventures | London, England, United Kingdom (UK) | 51-200 | 2008 | 37 |
Cvc | Luxembourg | 1001-5000 | 2005 | 16 |
Unilever | London, England, United Kingdom (UK) | 10001+ | 1872 | 0 |
Apax | London, England, United Kingdom (UK) | 201-500 | 1981 | 8 |
Index Ventures | London, England, United Kingdom (UK) | 51-200 | 1996 | 67 |
Eurazeo | Paris, Île-De-France, France | 201-500 | 1969 | 40 |
Partech | Paris, Île-De-France, France | 51-200 | 1982 | 24 |
Want to find more investors focusing on the dermatology practice industry?
If you want to find more investors that are active in the dermatology practiceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.With Inven, you'll also get to know:
- Deal History: Number of deals and their sizes.
- Portfolio: Companies they've invested in.
- Contact data: Key dealmakers, including their emails and phonenumbers.
- ...and much more!
Trusted by 700+ companies

















